Contact this trialFirst, we need to learn more about you.
Anti-metabolites
Inclisiran for Coronary Artery Disease
Recruiting2 awardsPhase 3
New York, New York
This trial aims to study whether controlling cardiovascular risk factors in young adults without known heart disease can reduce the progression of atherosclerosis. The study will enroll 1,600 healthy young adults and randomize
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service